Image de couverture de livre

Venetoclax and Homoharringtonine‐Based Therapy Exhibited a Striking Response in Refractory/Relapsed Early T‐Cell Precursor Acute Lymphoblastic Leukemia

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Xiang Zhang, Hongsheng Zhou, Liping Mao, Yinjun Lou, Lijing Shen, Ying Lu, Zhenfang Liu, Xiuzhen Tong, Aiping Zhang, Tingbo Liu, Na Zhang, Xingnong Ye, Juying Wei, Meihong Luo, Shaoyuan Wang, Qingxian Bai, Jian Hou, Qifa Liu, Hongyan Tong, Jie Jin, Wenjuan Yu
Format:	Artículo Open Access
Publié:	Wiley 2025
Sujets:	MedComm
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Homoharringtonine in Relapsed/Refractory Paediatric T‐Cell Acute Lymphoblastic Leukaemia—A Case Series and a Report on the Use of In Vitro Drug Profiling
par: Pui Yung Grace Tong, et autres
Publié: (2025)

Venetoclax Combined With Chemotherapy in Pediatric and Adolescent/Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia
par: Andrew E. Place, et autres
Publié: (2025)

Chidamide in Combination With DCAG With or Without Venetoclax for Relapsed/Refractory Acute Myeloid Leukemia
par: Qingyang Liu, et autres
Publié: (2025)

Venetoclax Plus Daratumumab Bridging Allo‐HSCT in Early T‐Cell Precursor Acute Lymphoblastic Leukemia
par: Fanqiao Meng, et autres
Publié: (2025)

Durable MRD‐Negative Remission With Blinatumomab and Venetoclax in Heavily Pretreated Relapsed/Refractory Philadelphia Chromosome‐Positive Acute Lymphoblastic Leukemia
par: Mohammad Shahzaib Qadir, et autres
Publié: (2026)

Venetoclax Combined With FLAG‐IDA in Refractory or Relapsed Acute Myeloid Leukemia
par: Kai Wille, et autres
Publié: (2024)

Selinexor and Venetoclax Combination in Patients With Relapsed or Refractory Acute Myeloid Leukemia
par: Somedeb Ball, et autres
Publié: (2026)

Treatment of Relapsed/Refractory t(11;14) Multiple Myeloma and High‐Risk Myelodysplastic Syndrome With Venetoclax
par: Allison O. Taylor, et autres
Publié: (2025)

Clinical Outcomes of CD7 CAR‐T Cell Therapy in Relapsed or Refractory T‐Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma Patients
par: Jinyan Xiao, et autres
Publié: (2025)

Venetoclax or Pirtobrutinib in Relapsed/Refractory Waldenström Macroglobulinemia: Clinical and Molecular Predictors and Sequencing Implications
par: Alberto Guijosa, et autres
Publié: (2026)

Correction to “Venetoclax‐Based Therapy for Relapsed or Refractory Acute Myeloid Leukaemia Following Intensive Induction Chemotherapy”
Publié: (2025)

A Phase 2 Trial of CPX‐351 Combined With Venetoclax in Relapsed or Refractory Acute Myeloid Leukemia
par: Tapan M. Kadia, et autres
Publié: (2025)

Venetoclax in Pediatric and Young Adult Patients With Relapsed/Refractory Solid Tumors: Results of a Phase 1 Study
par: Daniel A. Morgenstern, et autres
Publié: (2026)

Venetoclax Alone or in Combination With Chemotherapy in Paediatric and Adolescent/Young Adult Patients With Relapsed/Refractory Acute Myeloid Leukaemia
par: Seth E. Karol, et autres
Publié: (2025)

Venetoclax plus daunorubicin and cytarabine in newly diagnosed acute myeloid leukemia patients: A propensity score‐matched analysis
par: Rong Wang, et autres
Publié: (2024)

Clinical Experience With Venetoclax‐Based Combinations for Relapsed/Refractory or MRD ‐Positive NPM1 ‐Mutated Acute Myeloid Leukemia
par: Matteo Piccini, et autres
Publié: (2026)

Potential Off‐Target Effect of Gilteritinib With Venetoclax Decreases Tumor Burden for Patients With Relapsed/Refractory Wild‐Type FLT3 Acute Myeloid Leukemia/Myelodysplastic Neoplasms
par: Shuting Chang, et autres
Publié: (2025)

Novel Fusion Gene Transcripts and Targetable Mutations in High‐Risk B‐ ALL With Exceptional Response to Venetoclax‐Based Therapy
par: Jifang Tu, et autres
Publié: (2026)

Daratumumab for CD20 − CD38 + Relapsed/Refractory Diffuse Large B‐Cell Lymphoma
par: ZeTong Hong, et autres
Publié: (2025)

Known Prognostic Models Fail to Predict Outcomes for Venetoclax and Azacitidine in Relapsed/Refractory Acute Myeloid Leukemia: A Single‐Center Retrospective Analysis
par: Jason S. Gilbert, et autres
Publié: (2025)

A Case Series and Literature Review on Zanubrutinib Therapy for the Treatment of Relapsed/Refractory Immune Thrombocytopenia
par: Bingjie Ding, et autres
Publié: (2025)

Short‐Course Blinatumomab Treatment as a Bridge to Further Salvage Therapy for Relapsed/Refractory B‐Cell Acute Lymphoblastic Leukemia: A Retrospective Single‐Center Study
par: Jin Yin, et autres
Publié: (2024)

Venetoclax–Azacitidine Versus Azacitidine for the Treatment of Primary Refractory or First Relapsed Acute Myeloid Leukemia. An IPC‐DATAML‐MSKCC Retrospective Study
par: Cassandre Petit, et autres
Publié: (2025)

Therapeutic Strategies for Relapsed or Refractory B‐Cell Acute Lymphoblastic Leukemia in Adult Patients: Optimizing the Use of Monoclonal Antibodies
par: Antonella Bruzzese, et autres
Publié: (2025)

$b\to s\ell^+\ell^- (\ell = e, μ, τ)$ and $b\to sν\barν$ at Belle and Belle II
par: Liu, Meihong
Publié: (2026)

Measurements of electroweak penguin and lepton-flavour violating $B$ decays to final states with missing energy at Belle and Belle~II
par: Liu, Meihong
Publié: (2026)

Correction to “Analysis of 60 Patients with Relapsed or Refractory T‐cell Acute Lymphoblastic Leukemia and T‐cell Lymphoblastic Lymphoma Treated with CD7 ‐targeted Chimeric Antigen Receptor‐T Cell Therapy”
Publié: (2024)

Venetoclax‐Based Therapy for Early Relapse in Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report and Minireview
par: Yufeng Du, et autres
Publié: (2025)

Correction to “Real‐World Data on Inotuzumab Ozogamicin for Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia: A GRELAL ‐Chile Study”
Publié: (2025)

Histone Lactylation‐Mediated RANKL Activation in Early T‐Cell Precursor Acute Lymphoblastic Leukemia Impairs Neural Stem Cell Self‐Renewal During CNS Infiltration
par: Lan Li, et autres
Publié: (2026)

A Nomogram Combining Two Novel Biomarkers for Predicting Lung Adenocarcinoma in Ground‐Glass Nodule Patients
par: Yameng Li, et autres
Publié: (2025)

Therapy Sequencing in Relapsed/Refractory MCL
par: Eva Giné
Publié: (2025)

Multicenter Real‐World Analysis of Glofitamab in Relapsed/Refractory Primary CNS Lymphoma: Clinical Activity, CNS Penetration, and ctDNA Dynamics
par: Apeng Yang, et autres
Publié: (2026)

FouriScale: A Frequency Perspective on Training-Free High-Resolution Image Synthesis
par: Huang, Linjiang, et autres
Publié: (2024)

Trametinib Monotherapy in the Treatment of Pediatric Refractory/Relapse Langerhans Cell Histiocytosis
par: Wenqian Wang, et autres
Publié: (2026)

The Oxidative C−C Bond Cleavage for the Valorization of Lignin
par: Shaoyuan Guo, et autres
Publié: (2024)

Advances in the Management of Relapsed/Refractory CLL and Richter Transformation
par: Nathalie Javidi‐Sharifi, et autres
Publié: (2025)

Abdominal Imaging at Initial Diagnosis and Following Relapse in Children With Acute Lymphoblastic Leukaemia
par: Luke R. Holmes, et autres
Publié: (2026)

Unraveling the Emotions of an English as a Foreign Language Teacher and Their Impact on Professional Identity in Teaching Reform
par: Wen Liu, et autres
Publié: (2025)

A class of forward-backward regularizations of the Perona-Malik equation with variable exponent
par: Tong, Yihui, et autres
Publié: (2025)